Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: The national survey of risk factors for noncommunicable diseases of Iran

American Journal of Hypertension

Volumn 21, Issue 6, 2008, Pages 620-626

  Esteghamati, Alireza ^a   Abbasi, Mehrshad ^a   Alikhani, Siamak ^b   Gouya, Mohamad M ^b   Delavari, Alireza ^b   Shishehbor, Mehdi H ^c   Forouzanfar, Mehrdad ^a,d   Hodjatzadeh, Alieh ^b   Ramezani, Rashid D ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c LERNER RESEARCH INSTITUTE   (United States)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTHROPOMETRY; ARTICLE; AWARENESS; CARDIOVASCULAR RISK; COMMUNICABLE DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; IRAN; KNOWLEDGE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS;

EID: 44349090557     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.154     Document Type: Article

References (43)

1. De Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, Carmona J. Prevalence, awareness, treatment and control of hypertension in Portugal. The PAP study. Rev Port Cardiol 2007; 26:21-39.
2. Perez-Fernandez R, Marino AF, Cadarso-Suarez C, Botana MA, Tome MA, Solache I, Rego-Iraeta A, Mato AJ. Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. J Hum Hypertens 2007; 21:366-373.
3. Petrella RJ, Merikle EP, Jones J. Prevalence, treatment, and control of hypertension in primary care: gaps, trends, and opportunities. J Clin Hypertens (Greenwich) 2007; 9:28-35.
4. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49:69-75.
5. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health 2006; 27:465-490.
6. Agyemang C, Ujcic-Voortman J, Uitenbroek D, Foets M, Droomers M. Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: the Amsterdam Health Monitor Survey. J Hypertens 2006; 24:2169-2176.
7. Pitsavos C, Milias GA, Panagiotakos DB, Xenaki D, Panagopoulos G, Stefanadis C. Prevalence of self-reported hypertension and its relation to dietary habits, in adults; a nutrition & health survey in Greece. BMC Public Health 2006; 6:206.
8. Choi KM, Park HS, Han JH, Lee JS, Lee J, Ryu OH, Lee KW, Cho KH, Yoon D, Baik SH, Choi DS, Kim SM. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens 2006; 24:1515-1521.
9. Mancia G, Parati G, Borghi C, Ghironzi G, Andriani E, Marinelli L, Valentini M, Tessari F, Ambrosioni E. SMOOTH investigators. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens 2006; 24:837-843.
10. He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999; 138:211-219.
11. Lopez AD. Assessing the burden of mortality from cardiovascular diseases. World Health Stat Q 1993; 46: 91-96.
12. He J, Klag MJ, Wu Z, Whelton PK. Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke. Stroke 1995; 26: 2228-2232.
13. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-313.
14. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds RF, Su S, Whelton PK, He J. InterASIA Collaborative Group. The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002;40:920-927.
15. Azizi F, Ghanbarian A, Madjid M, Rahmani M. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000. J Human Hypertens 2002; 16:305-312.
16. Sadeghi M, Roohafza HR, Kelishadi R. Blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme.Med J Malaysia. 2004; 59:460-467.
17. Delavari AR, Alikhani S, Alaedini F. A National Profile of Non-Communicable Disease Risk Factors in the I.R.of Iran. Center for Disease Control, Ministry of Health & Medical Education, Tehran 2005.
18. STEPwise approach to chronic disease risk factor surveillance (STEPS) 〈http://www.who.int/chp/steps/manual/en/index.html〉 (2003). Accessed 3 January 2008.
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, the National High Blood Pressure Education Program Coordinating Committee. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2572.
20. Kim JS, Jones DW, Kim SJ, Hong YP. Hypertension in Korea: a national survey. Am J Prev Med 1994; 10: 200-204.
21. Tatsanavivat P, Klungboonkrong V, Chirawatkul A, Bhuripanyo K, Manmontri A, Chitanondh H, Yipintsoi T. Prevalence of coronary heart disease and major cardiovascular risk factors in Thailand. Int J Epidemiol 1998; 27: 405-409.
22. Pan W, Chang H, Yeh W, Hsiao S, Hung Y. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of nutrition and health survey in Taiwan (NAHSIT), 1993-1996. J Hum Hypertens 2001; 15:793-798.
23. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the health survey for England 1998. Hypertension 2001; 38:827-832.
24. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10:1097-1102.
25. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
26. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43:10-17.
27. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005; 294:466-472.
28. Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens 2004; 18:545-551.
29. Gupta R, Gupta VP, Ahluwalia NS. Educational status, coronary heart disease, and coronary risk factor prevalencein a rural population of India. BMJ 1994; 309:1332-1336.
30. Jaddou1 HY, Bateiha1 AM, Ajlouni KM. Prevalence, awareness and management of hypertension in a recently urbanised community, eastern Jordan. J Hum Hypertens 2000; 14:497-501.
31. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
32. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289:2363-2369.
33. Cappuccio FP, Micah FB, Emmett L, Kerry SM, Antwi S, Martin-Peprah R, Phillips RO, Plange-Rhule J, Eastwood JB. Prevalence, Detection, Management, and Control of Hypertension in Ashanti, West Africa. Hypertension 2004; 43:1017-1022.
34. Banegas JR, Rodríguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillón P, del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension. 1998; 32:998-1002.
35. Tsai PS, Ke TL, Huang CJ, Tsai JC, Chen PL, Wang SY, Shyu YK. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005; 23:1355-1360.
36. Brown DJ, Metiko EB. Prevalence of hypertension in a sample of Black American adults using JNC 7 classifications. J Natl Black Nurses Assoc 2005; 16:1-5.
37. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit 2005; 11:CR403-CR409.
38. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005; 36:1859-1863.
39. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, Howard BV. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006; 47:410-414.
40. Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension 2006; 48:254-259.
41. Thefeld W. Verbreitung der herz-kreislauf-risikofaktoren hypercholesterinämie, übergewicht, hypertonie und rauchen in der Bevölkerung. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2000; 43:415-423.
42. Gupta R, Gupta VP, Sarna M, Bhatnagar S, Thanvi J, Sharma V, Singh AK, Gupta JB, Kaul V. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur heart watch-2. Indian Heart J 2002; 54:59-66.
43. Sarraf-Zadegan N, Boshtam M, Mostafavi S, Rafiei M. Prevalence of hypertension and associated risk factors in Isfahan, Islamic Republic of Iran. East Mediterr Health J 1999; 5: 992-1001.